Int J Chron Obstruct Pulmon Dis
April 2024
Background: Several studies have shown that the risk of mortality due to COVID-19 is high in patients with COPD. However, evidence on factors predicting mortality is limited.
Research Question: Are there any useful markers to predict mortality in COVID-19 patients with COPD?.
Eur Rev Med Pharmacol Sci
November 2022
Objective: Pulmonary actinomycosis is a rare and chronic infectious disease that mimics malignancy and is frequently misdiagnosed. There are few reports that address the clinical characteristics of pulmonary actinomycosis. The objective of this research is to evaluate the clinical features, radiological findings, diagnostic approaches and treatment outcomes of pulmonary actinomycosis.
View Article and Find Full Text PDFBackground: While mortality rates decrease in many chronic diseases, it continues to increase in COPD. This situation has led to the need to develop new approaches such as phenotypes in the management of COPD. We aimed to investigate the distribution, characteristics and treatment preference of COPD phenotypes in Turkey.
View Article and Find Full Text PDFEur Rev Med Pharmacol Sci
April 2022
Objective: The number patients surviving COVID-19 hospitalization is steadily increasing. Follow-up management for these patients relies on an understanding of the long-term effects of COVID-19. Specifically, there are insufficient data about the lasting effects of COVID-19 on bone health.
View Article and Find Full Text PDFObjective: This study aimed to review the risk factors for silicosis together with survival analysis and a perspective for lung transplantation with data from a single center.
Material And Methods: We reviewed the medical records of denim sandblasters who were referred to our center between January 2006 and December 2011 and evaluated 219 patients with a history of denim sandblasting with a minimum follow-up period of 5 years until 2016. We analyzed several personal and occupational features, together with functional and radiologic data.